Publication | Closed Access

Efficient access to novel androsteno-17-(1′,3′,4′)-oxadiazoles and 17β-(1′,3′,4′)-thiadiazoles via N-substituted hydrazone and N,N′-disubstituted hydrazine intermediates, and their pharmacological evaluation in vitro

Molecular PharmacologyDiversity Oriented SynthesisPharmaceutical ChemistryMedicineN′-disubstituted Hydrazine IntermediatesChemistryDrug DevelopmentEfficient AccessPharmacologyN-substituted HydrazoneDrug Discovery